https://www.reedland.com/wp-content/uploads/2017/04/NeoRx.jpg
292
560
reedland
https://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.png
reedland2004-02-23 12:42:462017-04-26 13:03:43NeoRx Completes $9.7 Million Common Stock Financing
https://www.reedland.com/wp-content/uploads/2017/04/Arena-Pharmaceuticals.jpg
292
560
reedland
https://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.png
reedland2003-12-24 13:04:142017-04-26 13:21:36Arena Pharmaceuticals Completes $35 Million Private Placement
https://www.reedland.com/wp-content/uploads/2017/04/NeoRx.jpg
292
560
reedland
https://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.png
reedland2003-12-08 13:22:102017-04-26 13:32:41NeoRx Completes $15.75 Million Preferred Stock Financing
https://www.reedland.com/wp-content/uploads/2017/04/Reliant-Pharmaceuticals.jpg
292
560
reedland
https://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.png
reedland2003-09-30 13:45:142017-04-26 13:49:18Reliant Pharmaceuticals Announces $115 Million Initial Closing of Series D Convertible Preferred Units
Scroll to top